Company

Press

Nov 08, 2016

AiCure is awarded twentieth patent for artificial intelligence platform

Oct 27, 2016

AiCure announces new results from Phase 2 Takeda study demonstrating up to 96.7% adherence in patients post hospital discharge

Oct 20, 2016

Randomized controlled trial shows 67% increase in adherence in patients with ischemic stroke

Sep 30, 2016

AiCure winner of AIconics award announced at The AI Summit in San Francisco, 28 September

Sep 26, 2016

AiCure announces new study results demonstrating 90% adherence from Phase 2 Abbvie study

Jan 11, 2016

AiCure's Artificial Intelligence Platform Draws $12.25 Million Series A.

Nov 10, 2015

AiCure awarded 11th patent for AI Platform

Oct 09, 2015

AiCure invited to be part of leadership council for Clinical Trials of The Future, led by Dr. Amir Kalali

Sep 10, 2015

Presenting at the annual Dpharm: Disruptive Innovations